| Primary |
| Iron Deficiency Anaemia |
30.7% |
| Drug Use For Unknown Indication |
24.1% |
| Anaemia |
15.7% |
| Iron Deficiency |
6.0% |
| Anaemia Of Malignant Disease |
3.6% |
| Product Used For Unknown Indication |
3.0% |
| Renal Failure Chronic |
2.4% |
| Crohn's Disease |
1.8% |
| Prophylaxis |
1.8% |
| Testis Cancer |
1.8% |
| Bone Pain |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypertension |
1.2% |
| Supplementation Therapy |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Accidental Exposure |
0.6% |
| Depression |
0.6% |
| Haemoglobin Decreased |
0.6% |
| Haemorrhagic Anaemia |
0.6% |
| Iron Deficiency Anemia |
0.6% |
|
| Dyspnoea |
11.1% |
| Anaphylactic Reaction |
9.9% |
| Death |
9.9% |
| Infusion Related Reaction |
7.4% |
| Throat Tightness |
6.2% |
| Hypotension |
4.9% |
| Pruritus |
4.9% |
| Vomiting |
4.9% |
| Wheezing |
4.9% |
| Dizziness |
3.7% |
| Oxygen Saturation Decreased |
3.7% |
| Pyrexia |
3.7% |
| Respiratory Distress |
3.7% |
| Throat Irritation |
3.7% |
| Urticaria |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Cardiac Arrest |
2.5% |
| Feeling Hot |
2.5% |
| Hyperhidrosis |
2.5% |
| Nausea |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.3% |
| Iron Deficiency Anaemia |
16.7% |
| Bone Pain |
8.9% |
| Crohn's Disease |
7.8% |
| Prophylaxis |
6.7% |
| Anaemia |
5.6% |
| Gastrooesophageal Reflux Disease |
4.4% |
| Insomnia |
4.4% |
| Product Used For Unknown Indication |
4.4% |
| Sinusitis |
4.4% |
| Depression |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hypertension |
2.2% |
| Supplementation Therapy |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Gastric Cancer |
1.1% |
| Iron Deficiency |
1.1% |
|
| Visual Acuity Reduced |
36.4% |
| Pyrexia |
13.6% |
| Flank Pain |
9.1% |
| Anaemia |
4.5% |
| Anaphylactic Reaction |
4.5% |
| Dyspnoea |
4.5% |
| Furuncle |
4.5% |
| Skin Discolouration |
4.5% |
| Unresponsive To Stimuli |
4.5% |
| Urinary Incontinence |
4.5% |
| Urticaria |
4.5% |
| Wheezing |
4.5% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
21.8% |
| Product Used For Unknown Indication |
9.3% |
| Pain |
8.3% |
| Hypotension |
7.7% |
| Sleep Disorder |
6.4% |
| Hormone Replacement Therapy |
5.8% |
| Non-small Cell Lung Cancer |
4.8% |
| Drug Use For Unknown Indication |
4.5% |
| Mineral Supplementation |
4.2% |
| Eczema |
3.2% |
| Neoplasm Malignant |
3.2% |
| Prostate Cancer Metastatic |
3.2% |
| Anaemia |
2.6% |
| Breast Cancer |
2.6% |
| Hyperlipidaemia |
2.6% |
| Muscle Spasms |
2.2% |
| Surgery |
2.2% |
| Nausea |
1.9% |
| Prostate Cancer |
1.9% |
| Angiogram |
1.6% |
|
| Skin Tightness |
11.1% |
| Skin Turgor Decreased |
11.1% |
| Weight Decreased |
11.1% |
| Therapeutic Response Decreased |
9.3% |
| Metabolic Encephalopathy |
7.4% |
| Vomiting |
7.4% |
| White Blood Cell Count Decreased |
7.4% |
| Breast Cancer Female |
5.6% |
| Skin Ulcer |
5.6% |
| Tendon Disorder |
5.6% |
| Arthralgia |
1.9% |
| Asthenia |
1.9% |
| Chest Pain |
1.9% |
| Death |
1.9% |
| Dizziness |
1.9% |
| Dyspnoea |
1.9% |
| Fatigue |
1.9% |
| Flushing |
1.9% |
| Gait Disturbance |
1.9% |
| Hospitalisation |
1.9% |
|
